ARCHIVES

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

This article is from The Cancer Letter archive.

Vol. 15 No. 44 | November 17, 1989

Download PDF Visit The Full Archive

Related Articles

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986

NCCS Networker Volume 10 Issue 3, Winter 1996

January 13, 1996

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

October 25, 1985

Tobacco Interests Contribute a Portion Of the $109 Million Raised by Stand Up To Cancer

September 12, 2014

Senate Subcommittee Seeking $2 Billion In for NIH, Bumps Up Against Caps

June 25, 1999

DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes

March 4, 1988